Alastin Skincare, Inc. has announced the appointment of Amber Edwards as chief commercial officer.
She most recently served as president of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan, Inc. where she was the vice president of international strategic marketing, medical esthetics franchise, in the United Kingdom.
Edwards also has experience with Allergan in the United States, in both esthetic and therapeutic areas. She began her career in sales and marketing roles at Pfizer.
“We are extremely pleased to have Amber Edwards join Alastin as a key member of the executive team to lead our U.S. and international commercialization activities as we continue the rapid growth of our company,” Diane S. Goostree, president and CEO of Alastin Skincare, said. “[Edward’s] strategic perspectives and global experience will be extremely helpful as we leverage our innovative science and products and expand our footprint in the esthetic marketplace.”
“I am thrilled to join an organization that has made such a notable mark in a crowded segment, and at a time they are experiencing tremendous opportunity and momentum,” Edwards said. “Alastin has demonstrated a commitment to science and ultimately to patients, identifying an innovative approach to helping physicians maximize patient results. I believe they have only scratched the surface and am honored to lead the commercial path forward.”